P

Protagonist Therapeutics
D

PTGX

128.800
USD
-7.59
(-5.56%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
33,258
الربح لكل سهم
4
العائد الربحي
-
P/E
125
حجم السوق
8,334,427,108
أصول ذات صلة

العنوان: Protagonist Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.